Author: Nancy Ogbonna

Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates?

by Nancy Ogbonna - 036

Evidence-based clinical review Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates? A prognosis- and goals-based approach to preventive medications, with important exceptions for recent ASCVD, high fracture risk, and active cancer indications Estimated

Perioperative Antibiotic Prophylaxis in 2026: Shorter, Narrower, Smarter, and Still Controversial

by Nancy Ogbonna - 059

Evidence-based clinical review Perioperative Antibiotic Prophylaxis in 2026 Shorter, Narrower, Smarter, and Still Controversial Estimated reading time: 15 minutes Abstract Background Perioperative antibiotic prophylaxis prevents surgical site infection only when the right drug reaches the operative

Continuous Glucose Monitoring Beyond Insulin: Evidence, OTC Systems, and Data Interpretation for Family Medicine

by Nancy Ogbonna - 030

Evidence-based clinical review Continuous Glucose Monitoring Beyond Insulin Evidence, OTC Systems, and Data Interpretation for Family Medicine A practical framework for selecting professional, prescription, or over-the-counter CGM and converting an ambulatory glucose profile into safe clinical decisions Estimated reading time: 15 minutes

Blood-Based Colorectal Cancer Screening in Family Practice: Where Shield Fits Among FIT, Stool DNA, and Colonoscopy

by Nancy Ogbonna - 057

Evidence-based clinical review Blood-Based Colorectal Cancer Screening in Family Practice: Where Shield Fits Among FIT, Stool DNA, and Colonoscopy A practical framework for average-risk adults who remain unscreened or decline preferred modalities Abstract Background: The U.S. Food

Real-World Evidence vs Randomized Trials in Oncology: When Should Practice Change?

by Nancy Ogbonna - 046

Evidence-based clinical review Real-World Evidence vs Randomized Trials in Oncology When Should Practice Change Estimated reading time: 15 minutes Abstract Background: Oncology increasingly relies on evidence generated outside conventional randomized controlled trials. This is particularly true

Falls as a Cardiovascular Symptom: Hidden Orthostatic Hypotension, Atrial Fibrillation Therapies, and When Pacemakers Help

by Nancy Ogbonna - 083

Evidence-based clinical review Falls as a Cardiovascular Symptom Hidden Orthostatic Hypotension, Atrial Fibrillation Therapies, and When Pacemakers Help Estimated reading time: 15 minutes Abstract Background: While falls in older adults are typically multifactorial, a clinically significant

Multi-Cancer Early Detection Blood Tests in Family Practice: Clinical Promise, False Positives, and the Risks of Premature Adoption

by Nancy Ogbonna - 038

Evidence-based clinical review Multi-Cancer Early Detection Blood Tests in Family Practice: Clinical Promise, False Positives, and the Risks of Premature Adoption Updated: September 2, 2026 | Estimated reading time: 15 minutes Abstract Background Multi-cancer early detection

Outpatient Community-Acquired Pneumonia in 2026: Are We Still Treating Too Broadly?

by Nancy Ogbonna - 087

Evidence-based clinical review Outpatient Community-Acquired Pneumonia in 2026: Are We Still Treating Too Broadly? Updated: September 2, 2026 | Estimated reading time: 15 minutes Abstract Background Outpatient community-acquired pneumonia (CAP) is a common setting for

Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates?